Unknown

Dataset Information

0

Antifibrotic therapies in liver disease: Ready for primetime?

ABSTRACT:

SUBMITTER: Rudnick DA 

PROVIDER: S-EPMC6467161 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antifibrotic therapies in liver disease: Ready for primetime?

Rudnick David A DA  

Clinical liver disease 20170629 6

Similar Datasets

Unknown Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
| S-EPMC12276452 | biostudies-literature
Unknown Antifibrotic therapies in the liver.
| S-EPMC5743222 | biostudies-literature
Unknown Is fat taste ready for primetime?
| S-EPMC4162865 | biostudies-literature
Unknown Current status of novel antifibrotic therapies in patients with chronic liver disease.
| S-EPMC3187682 | biostudies-literature
Unknown Iron Therapy in Heart Failure: Ready for Primetime?
| S-EPMC5971676 | biostudies-literature
Unknown Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis.
| S-EPMC9104939 | biostudies-literature
Unknown Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
| S-EPMC7508785 | biostudies-literature
Unknown Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?
| S-EPMC11676598 | biostudies-literature
Unknown Polygenic risk score (PRS) as prostate cancer screening: ready for primetime?
| S-EPMC12432619 | biostudies-literature
Unknown Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?
| S-EPMC7230166 | biostudies-literature